The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 25,509 | 2,199,011 | SH | SOLE | 2,199,011 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 39,208 | 2,600,014 | SH | SOLE | 2,600,014 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 128,911 | 3,688,448 | SH | SOLE | 3,688,448 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 10,629 | 1,312,258 | SH | SOLE | 1,312,258 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 19,798 | 1,887,332 | SH | SOLE | 1,887,332 | 0 | 0 | ||
| IGNYTA INC | COM | 451731103 | 26,844 | 2,173,593 | SH | SOLE | 2,173,593 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 16,960 | 2,188,331 | SH | SOLE | 2,188,331 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM | 82640U107 | 12,574 | 8,112,121 | SH | SOLE | 8,112,121 | 0 | 0 | ||